Wells Fargo Starts Kestra Medical Technologies (KMTS) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
BofA Securities Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 6:52 AM EDTBofA Securities analyst Travis Steed initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Wolfe Research Starts Kestra Medical Technologies (KMTS) at Outperform
March 31, 2025 5:19 AM EDTWolfe Research analyst Mike Polark initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Goldman Sachs Starts Kestra Medical Technologies (KMTS) at Neutral
March 31, 2025 5:12 AM EDTGoldman Sachs analyst David Roman initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Neutral rating and a price target of $24.00.
The analyst comments "We initiate coverage on the shares of Kestra Medical Technologies (KMTS) with a Neutral rating and a 12-month price target... More
Piper Sandler Starts Kestra Medical Technologies (KMTS) at Overweight
March 31, 2025 3:55 AM EDTPiper Sandler analyst Matt O\'Brien initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Overweight rating and a price target of $27.00.
The analyst comments: "We are initiating Kestra Medical with an OW rating and $27 price target. The company boasts a unique, wearable... More
Stifel Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 2:07 AM EDTStifel analyst Rick Wise initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $28.00.
The analyst comments: "We are initiating coverage of Kestra (KMTS) with a Buy rating and $28 target price. This assumes KMTS trades at 9x our CY2027E... More
